Jingsong Wang
Tracked across 3 events · 19 articles · First seen Jun 10, 2026 · Last active Sep 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Jingsong Wang, as the Founder, Chairman, and CEO of Harbour BioMed, expressed satisfaction with the NMPA's acceptance of the IND application for HBM7004, highlighting the company's strategy in developing differentiated immunotherapies.
Jun 10, 2026 · 7 articles
Business
Solstice Oncology, a clinical-stage immuno-oncology company focused on neoadjuvant cancer treatment, launched with a $225 million Series A financing led by RA Capital Management, with participation from Canaan Partners, Forbion Ventures and other investors. The…
Impact: As Founder, Chairman and CEO of Harbour BioMed, Jingsong Wang commented on the launch and the continued development of porustobart.
Sep 09, 2026 · 6 articles
Business
Impact: Jingsong Wang>>>, CEO of Harbour BioMed>>>, expressed enthusiasm for Dhavalkumar Patel>>>'s appointment.
Jun 12, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Jingsong Wang live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard